Diana Chaker

Evry, 91100, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages.

A novel Chimeric Antigen Receptor (CAR) - strategy to target EGFRVIII-mutated glioblastoma cells via macrophages.

Journal: BMC cancer
Published: March 11, 2026

Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round.

Toward standardized iPSC testing: Insights from a multi-year international Quality Assessment Round.

Journal: Stem cell reports
Published: November 27, 2025

Mesenchymal stem cells and platelet rich plasma in the treatment of premature ovarian insufficiency: a scoping review.

Mesenchymal stem cells and platelet rich plasma in the treatment of premature ovarian insufficiency: a scoping review.

Journal: Contraception and reproductive medicine
Published: November 25, 2024

Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities.

Comparative analysis of iPSC-derived NK cells from two differentiation strategies reveals distinct signatures and cytotoxic activities.

Journal: Frontiers in immunology
Published: July 12, 2024

Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).

Impact of the overexpression of the tyrosine kinase receptor RET in the hematopoietic potential of induced pluripotent stem cells (iPSCs).

Journal: Cytotherapy
Published: August 07, 2023

Direct Reprogramming of Hepatocytes Into JAK/Stat-Dependent LGR5+ Liver Cells Able to Initiate Intrahepatic Cholangiocarcinoma.

Direct Reprogramming of Hepatocytes Into JAK/Stat-Dependent LGR5+ Liver Cells Able to Initiate Intrahepatic Cholangiocarcinoma.

Journal: Stem cells (Dayton, Ohio)
Published: July 13, 2023

Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.

Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 05, 2023

Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance.

Case report: Long-term voluntary Tyrosine Kinase Inhibitor (TKI) discontinuation in chronic myeloid leukemia (CML): Molecular evidence of an immune surveillance.

Journal: Frontiers in oncology
Published: December 06, 2022

Patient-Derived iPSCs Reveal Evidence of Telomere Instability and DNA Repair Deficiency in Coats Plus Syndrome.

Patient-Derived iPSCs Reveal Evidence of Telomere Instability and DNA Repair Deficiency in Coats Plus Syndrome.

Journal: Genes
Published: June 01, 2022

Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy.

Evidence of Antitumor and Antimetastatic Potential of Induced Pluripotent Stem Cell-Based Vaccines in Cancer Immunotherapy.

Journal: Frontiers in medicine
Published: June 22, 2021

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology.

iPSC-Derived Organoids as Therapeutic Models in Regenerative Medicine and Oncology.

Journal: Frontiers in medicine
Published: June 21, 2021

iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression.

iPSC-Derived Hereditary Breast Cancer Model Reveals the BRCA1-Deleted Tumor Niche as a New Culprit in Disease Progression.

Journal: International journal of molecular sciences
Published: January 06, 2021
Showing 1-12 of 14

Last Updated: 09/26/2026